Lataa...
(99m)Tc-radiolabeled GE11-modified peptide for ovarian tumor targeting
BACKGROUND: Ovarian cancer is a serious threat for women health and the early diagnosis of this cancer might improves the survival rate of patients. The use of the targeted radiopharmaceuticals could be a non-invasive and logical method for tumor imaging. The aim of this study was to radiolabel GE11...
Tallennettuna:
| Julkaisussa: | Daru |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414288/ https://ncbi.nlm.nih.gov/pubmed/28464952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40199-017-0179-8 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|